An update on uncomplicated urinary tract infections in women

Current Opinion in Urology

Volumn 19, Issue 4, 2009, Pages 368-374

  Wagenlehner, Florian M E ^a   Weidner, Wolfgang ^a   Naber, Kurt G ^b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cystitis; Pyelonephritis; Recurrent urinary tract infection; Uncomplicated urinary tract infection

Indexed keywords

AMIKACIN; AMINOPENICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFEPIME; CEFOTAXIME; CEFPODOXIME PROXETIL; CEFTAZIDIME; CEFTIBUTEN; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; CRANBERRY EXTRACT; FOSFOMYCIN; FOSFOMYCIN TROMETAMOL; GENTAMICIN; LEVOFLOXACIN; MECILLINAM; NALIDIXIC ACID; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; OM 89; PIVMECILLINAM; PLACEBO; TRIMETHOPRIM; UNINDEXED DRUG;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; CYSTITIS; DISEASE PREDISPOSITION; ESCHERICHIA COLI; HUMAN; INFECTION PREVENTION; KLEBSIELLA PNEUMONIAE; MONOTHERAPY; PRIORITY JOURNAL; PROTEUS MIRABILIS; PYELONEPHRITIS; REVIEW; STAPHYLOCOCCUS SAPROPHYTICUS; THERAPY EFFECT; TOXIC EPIDERMAL NECROLYSIS; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; CYSTITIS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; PREVALENCE; PYELONEPHRITIS; RECURRENCE; URINARY TRACT INFECTIONS;

EID: 68249118391     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOU.0b013e32832ae18c     Document Type: Review

References (50)

1. Ferry SA, Holm SE, Stenlund H, et al. The natural course of uncomplicated lower urinary tract infection in women illustrated by a randomized placebo controlled study. Scand J Infect Dis 2004; 36:296-301. (Pubitemid 38714183)
2. Falagas ME, Kotsantis IK, Vouloumanou EK, Rafailidis PI. Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials. J Infect 2009; 58:91-102.
3. Ferry SA, Holm SE, Stenlund H, et al. Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: the LUTIW project. Scand J Prim Healthcare 2007; 25:49-57. (Pubitemid 46303851)
4. Christiaens TC, De Meyere M, Verschraegen G, et al. Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women. Br J Gen Pract 2002; 52:729-734. (Pubitemid 36187595)
5. Asbach HW. Single dose oral administration of cefixime 400mg in the treatment of acute uncomplicated cystitis and gonorrhoea. Drugs 1991; 42 (Suppl 4):10-13.
6. Brooks D, Garrett G, Hollihead R. Sulphadimidine, co-trimoxazole, and a placebo in the management of symptomatic urinary tract infection in general practice. J R Coll Gen Pract 1972; 22:695-703.
7. Dubi J, Chappuis P, Darioli R. Treatment of urinary infection with a single dose of co-trimoxazole compared with a single dose of amoxicillin and a placebo. Schweiz Med Wochenschr 1982; 112:90-92. (Pubitemid 12202226)
8. Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother 2003; 51:69-76. (Pubitemid 36163829)
9. Kahlmeter G. Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO. SENS study. Int J Antimicrob Agents 2003; 22 (Suppl 2):49-52. (Pubitemid 37188486)
10. Naber KG, Schito G, Botto H, et al. Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy. Eur Urol 2008; 54:1164-1175. The most recent pan-European surveillance study on uncomplicated cystitis.
11. Institute CaLS. Methods for dilution antimicrobial susceptibility testing. PA, USA: Clinical and Laboratory Standards Institute; 2007.
12. Lecomte F, Allaert FA. Single-dose treatment of cystitis with fosfomycin trometamol (Monuril): analysis of 15 comparative trials on 2048 patients. Giorn It Ost Gin 1997; 19:399-404. (Pubitemid 28037585)
13. Gupta K, Hooton TM, Roberts PL, Stamm WE. Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women. Arch Intern Med 2007; 167:2207-2212. (Pubitemid 350106740)
14. Spencer RC, Moseley DJ, Greensmith MJ. Nitrofurantoin modified release versus trimethoprim or co-trimoxazole in the treatment of uncomplicated urinary tract infection in general practice. J Antimicrob Chemother 1994; 33 (Suppl A):121-129.
15. Nicolle LE, Madsen KS, Debeeck GO, et al. Three days of pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women. Scand J Infect Dis 2002; 34:487-492. (Pubitemid 34906138)
16. Menday AP. Comparison of pivmecillinam and cephalexin in acute uncomplicated urinary tract infection. Int J Antimicrob Agents 2000; 13:183-187.
17. Arredondo-Garcia JL, Figueroa-Damian R, Rosas A, et al. Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study. J Antimicrob Chemother 2004; 54:840-843. (Pubitemid 39386743)
18. Richard GA, DeAbate CA, Ruoff GE, et al. A double-blind, randomised trial of the efficacy and safety of short-course, once-daily levofloxacin versus ofloxacin twice daily in uncomplicated urinary tract infection. Infect Dis Clin Pract 1998; 9:323-329.
19. Pimentel FL, Dolgner A, Guimaraes J, et al. Efficacy and safety of norfloxacin 800mg once-daily versus norfloxacin 400 mg twice-daily in the treatment of uncomplicated urinary tract infections in women: a double-blind, randomized clinical trial. J Chemother 1998; 10:122-127. (Pubitemid 28191105)
20. Kavatha D, Giamarellou H, Alexiou Z, et al. Cefpodoxime-proxetil versus trimethoprim-sulfamethoxazole for short-term therapy of uncomplicated acute cystitis in women. Antimicrob Agents Chemother 2003; 47:897-900. (Pubitemid 36254212)
21. Warren JW, Abrutyn E, Hebel JR, et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999; 29: 745-758. (Pubitemid 30256361)
22. Rafalsky V, Andreeva I, Rjabkova E. Quinolones for uncomplicated acute cystitis in women. Cochrane Database Syst Rev 2006; 3:CD003597.
23. Hooton TM, Scholes D, Gupta K, et al. Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial. JAMA 2005; 293:949-955. (Pubitemid 40271126)
24. Gleckman R, Bradley P, Roth R, et al. Therapy of symptomatic pyelonephritis in women. J Urol 1985; 133:176-178.
25. Stamm WE, McKevitt M, Counts GW. Acute renal infection in women: treatment with trimethoprim-sulfamethoxazole or ampicillin for two or six weeks. A randomized trial. Ann Intern Med 1987; 106:341-345. (Pubitemid 17029482)
26. Ode B, Broms M, Walder M, Cronberg S. Failure of excessive doses of ampicillin to prevent bacterial relapse in the treatment of acute pyelonephritis. Acta Med Scand 1980; 207:305-307. (Pubitemid 10149006)
27. Jernelius H, Zbornik J, Bauer CA. One or three weeks' treatment of acute pyelonephritis? A double-blind comparison, using a fixed combination of pivampicillin plus pivmecillinam. Acta Med Scand 1988; 223:469-477. (Pubitemid 18156098)
28. Johnson JR, Lyons MF 2nd, Pearce W, et al. Therapy for women hospitalized with acute pyelonephritis: a randomized trial of ampicillin versus trimethoprimsulfamethoxazole for 14 days. J Infect Dis 1991; 163:325-330.
29. Talan DA, Stamm WE, Hooton TM, et al. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial. JAMA 2000; 283:1583-1590.
30. Talan DA, Klimberg IW, Nicolle LE, et al. Once daily, extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis. J Urol 2004; 171 (2 Pt 1):734-739. (Pubitemid 38090470)
31. Naber KG, Bartnicki A, Bischoff W, et al. Gatifloxacin 200mg or 400mg once daily is as effective as ciprofloxacin 500mg twice daily for the treatment of patients with acute pyelonephritis or complicated urinary tract infections. Int J Antimicrob Agents 2004; 23 (Suppl 1):S41-53. (Pubitemid 38376049)
32. Richard GA, Klimberg IN, Fowler CL, et al. Levofloxacin versus ciprofloxacin versus lomefloxacin in acute pyelonephritis. Urology 1998; 52:51-55.
33. Naber KG, Schoenwald S, Hauke W. Cefpodoxime proxetil in patients with acute uncomplicated pyelonephritis. International, prospective, randomized comparative study versus ciprofloxacin in general practice. Chemotherapie J 2001; 10:29-34. (Pubitemid 32157143)
34. Peterson J, Kaul S, Khashab M, et al. A double-blind, randomized comparison of levofloxacin 750mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis. Urology 2008; 71:17-22. Double-blind, randomized studies, expressing modern considerations of dosing in the treatment of UTI.
35. Cronberg S, Banke S, Bergman B, et al. Fewer bacterial relapses after oral treatment with norfloxacin than with ceftibuten in acute pyelonephritis initially treated with intravenous cefuroxime. Scand J Infect Dis 2001; 33:339-343. (Pubitemid 32573982)
36. Klausner HA, Brown P, Peterson J, et al. A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500mg twice daily for 10 days in the treatment of acute pyelonephritis. Curr Med Res Opin 2007; 23:2637-2645. Double-blind, randomized studies, expressing modern considerations of dosing in the treatment of UTI.
37. Wells WG, Woods GL, Jiang Q, Gesser RM. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy. J Antimicrob Chemother 2004; 53 (Suppl 2):ii67-ii74. (Pubitemid 38807624)
38. Giamarellou H. Low-dosage cefepime as treatment for serious bacterial infections. J Antimicrob Chemother 1993; 32 (Suppl B):123-132. (Pubitemid 24025744)
39. Naber KG, Savov O, Salmen HC. Piperacillin 2 g/tazobactam 0.5 g is as effective as imipenem 0.5 g/cilastatin 0.5 g for the treatment of acute uncomplicated pyelonephritis and complicated urinary tract infections. Int J Antimicrob Agents 2002; 19:95-103. (Pubitemid 34163296)
40. Mouton YJ, Beuscart C. Empirical monotherapy with meropenem in serious bacterial infections. Meropenem Study Group. J Antimicrob Chemother 1995; 36 (Suppl A):145-156.
41. Wagenlehner FM, Wagenlehner C, Redman R, et al. Urinary bactericidal activity of doripenem versus levofloxacin in patients with complicated urinary tract infections or pyelonephritis. Antimicrob Agents Chemother 2009; 53:1567-1573.
42. Naber KG, Cho YH, Matsumoto T, Schaeffer AJ. Immunoactive prophylaxis of recurrent urinary tract infections: a meta-analysis. Int J Antimicrob Agents 2009; 33:111-119.
43. Bailey RR, Roberts AP, Gower PE, De Wardener HE. Prevention of urinarytract infection with low-dose nitrofurantoin. Lancet 1971; 2:1112-1114.
44. Raz R, Colodner R, Rohana Y, et al. Effectiveness of estriol-containing vaginal pessaries and nitrofurantoin macrocrystal therapy in the prevention of recurrent urinary tract infection in postmenopausal women. Clin Infect Dis 2003; 36:1362-1368. (Pubitemid 36702868)
45. Stamm WE, Wagner KF, Amsel R, et al. Causes of the acute urethral syndrome in women. N Engl J Med 1980; 303:409-415. (Pubitemid 10043636)
46. Brumfitt W, Hamilton-Miller JM, Smith GW, al-Wali W. Comparative trial of norfloxacin and macrocrystalline nitrofurantoin (macrodantin) in the prophylaxis of recurrent urinary tract infection in women. Q J Med 1991; 81:811-820.
47. Seppanen J. Cinoxacin vs trimethoprim: safety and efficacy in the prophylaxis of uncomplicated urinary tract infections. Drugs Exp Clin Res 1988; 14:669-671. (Pubitemid 19061758)
48. Rudenko N, Dorofeyev A. Prevention of recurrent lower urinary tract infections by long-term administration of fosfomycin trometamol. Drug Res 2005; 55:420-427.
49. Gower PE. The use of small doses of cephalexin (125 mg) in the management of recurrent urinary tract infection in women. J Antimicrob Chemother 1975; 1 (3 Suppl):93-98.
50. Brumfitt W, Hamilton-Miller JM. A comparative trial of low dose cefaclor and macrocrystalline nitrofurantoin in the prevention of recurrent urinary tract infection. Infection 1995; 23:98-102.